Raja Venkatraman recommends three stocks for 15 July
AI Summary
Indian equity markets experienced a significant downturn on July 14, with the Nifty 50 and Sensex closing sharply lower due to rising crude oil prices and negative global cues. Despite the overall decline, over 130 stocks reached new 52-week highs, indicating pockets of strength, while analysts suggest the Nifty remains resilient above 23,950, with potential upside if it can break above 24,300. Investors should monitor the 23,800 support level closely, as a breakdown could lead to increased selling pressure.
This is a Mint Premium article gifted to you.Subscribe to enjoy similar stories.
Tremors continue to be felt across the board as the market took the wind out of our sails yet again. The constant volatility that we are now subjected too is resulting in high level of confusion. As uncertainty is very much present in the system the steps ahead will be more measured.
Indian equity markets closed sharply lower on 14 July as rising crude oil prices and weak global cues weighed heavily on sentiment. The Nifty 50 slipped below 24,100 early in the session, with selling pressure intensifying in IT, auto, and banking stocks. By the close, the Sensex had dropped 561 points to 77,054, while the Nifty fell 159 points to 24,052, both settling near their day’s lows.
SBICARD: Buy above ₹639, stop ₹620 target ₹695 (Multiday)
BHARTIHEXA:Buy above ₹1625, stop ₹1555 target ₹1775 (Multiday)
LALPATHLAB:Buy above ₹1750, stop ₹1675 target ₹1900 (Multiday)
Broader indices struggled, with midcaps down 0.4% and smallcaps losing 1%. Realty, PSU banks, autos, and IT led sectoral declines, while pharma and metals provided some relief with modest gains. HCL Tech, Shriram Finance, HDFC Life, Tata Motors, and Interglobe Aviation were among the top losers, while Bharti Airtel, Apollo Hospitals, Sun Pharma, TCS, and Dr Reddy’s stood out as gainers.
Despite the weakness, over 130 stocks hit fresh 52-week highs, including Biocon, Welspun Corp, and Divis Labs. Analysts suggest the Nifty remains resilient above 23,950, with potential upside towards 24,250–24,300, though a break below support could trigger consolidation.
From a technical perspective, the Nifty appears to be in a consolidation phase. A look at the charts below we can see that the play of resistance continues to hold its weight over the trends in the last few sessions as we near the very important force that will contain the upmove. As ressitance and support zones have been defined for the month of February. The gap on the charts around the 23850 did create some volatility , however the higher levels remain pressured. Looking at charts the Average Directional Index is witnessing some sideways action as the expiry volatility took its toll. While bias remains positive there are sill some shorts in the system in the wake of the recent decline the possibility of range bound action cannot be ruled out between 23800 and 24300 leading us to play a wide range.
The index has formed a near-term resistance around 24,500, coinciding with the 20-day moving average. Momentum indicators such as RSI have cooled off from overbought territory, suggesting that the recent rally has lost steam and markets may remain range-bound in the short term.
In summary, July 8 once again stalled the three-day rally, with profit booking dominating trade. Traders should watch the 23,800-support zone closely, as a breakdown could accelerate selling, while a rebound above 24,300 may revive bullish momentum.
A look at the Option data reveals that the Max Pain point has now slid to 24050 as market is now indicating that the uptrend is now sealed until 24300 is surpassed. With mixed reactions on the floor the traders are remain supressed as the trends are seen hesitating. As PCR has now slipped to 1.05 with trends remaining mixed indicating a probable OI support is only near 24000 as clarity on the war front remains uncertain. Bank Nifty however will still be a preferred index as the trends in this index seems to be much stronger. As index debates, stock specific action continues.
Raja Venkatraman is co-founder, NeoTrader. His Sebi-registered research analyst registration no. is INH000016223.
Investments in securities are subject to market risks. Read all the related documents carefully before investing. Registration granted by Sebi and certification from NISM in no way guarantees performance of the intermediary or provide any assurance of returns to investors.
Disclaimer: The views and recommendations given in this...
Original Article
Published on Livemint